Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8513)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2013 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He C, Bian XY, Ni XZ, Shen DP, Shen YY, Liu H, Shen ZY, Liu Q. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer. World J Gastroenterol 2013; 19(14): 2171-2178 [PMID: 23599643 DOI: 10.3748/wjg.v19.i14.2171] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i14/2171.htm |
| Number | Citing Articles |
| 1 |
SU-QING ZHANG, KE-KANG SUN, XIAO-YANG WU, NING ZHONG, HUA ZHAO, DE-CHUN LI. Clinicopathological significance of cytoplasmic transducer of ErbB2. 1 expression in gastric cancer. Molecular Medicine Reports 2015; 12(1): 1177 doi: 10.3892/mmr.2015.3470
|
| 2 |
Diego Michelon DE CARLI, Marta Pires da ROCHA, Luis Carlos Moreira ANTUNES, Renato Borges FAGUNDES. IMMUNOHISTOCHEMICAL EXPRESSION OF HER2 IN ADENOCARCINOMA OF THE STOMACH. Arquivos de Gastroenterologia 2015; 52(2): 152 doi: 10.1590/S0004-28032015000200015
|
| 3 |
Yu-ying Lei, Jin-yu Huang, Qiong-rui Zhao, Nan Jiang, Hui-mian Xu, Zhen-ning Wang, Hai-qing Li, Shi-bo Zhang, Zhe Sun. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature. World Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1132-5
|
| 4 |
Duminda Subasinghe, Sivasuriya Sivaganesh, Ananthi Samarsekera, Mariyan Priyanthi Kumarasinghe, Dharmabandhu Nandadeva Samarasekera, Menaka Dilani Samarwickrema Lokuhetty. Human Epidermal Growth Factor Receptor-2 in Sri Lankan Gastric Carcinoma Patients with Clinicopathological Association and Survival. Digestive Diseases and Sciences 2017; 62(9): 2498 doi: 10.1007/s10620-017-4647-2
|
| 5 |
Danilo do Rosário Pinheiro, Wallax Augusto Silva Ferreira, Mariceli Baia Leão Barros, Mariana Diniz Araújo, Symara Rodrigues-Antunes, Bárbara do Nascimento Borges. Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications. World Journal of Gastroenterology 2014; 20(33): 11574-11585 doi: 10.3748/wjg.v20.i33.11574
|
| 6 |
Yanfeng Xi, Chen Xu, Yiqiang Liu, Xiaochu Yan, Chuansheng Huang, Yueping Liu, Jinhong Mei, Zhe Wang, Bin Liu, Xiaoming Li, Wencai Li, Jianyun Lan, Peng Gao, Jifeng Wu, Jianming Zheng, Yingyong Hou. The age variation of HER2 immunohistochemistry positive rate in biopsy specimens of gastric cancer. Pathology - Research and Practice 2020; 216(4): 152882 doi: 10.1016/j.prp.2020.152882
|
| 7 |
Ji-wang Liang, Jian-jun Zhang, Tao Zhang, Zhi-chao Zheng. Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature. Tumor Biology 2014; 35(5): 4849 doi: 10.1007/s13277-014-1636-3
|
| 8 |
Antonio Ieni, Giuseppe Angelico, Valeria Barresi, Giuseppe Giuffrè, Francesco Arena, Rosario Alberto Caruso, Giovanni Tuccari. Human Epidermal Growth Factor Receptor 2 Status in Gastric Carcinomas with Distinctive Prevalent Cribriform Component. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/1505428
|
| 9 |
Anna Pous, Lucía Notario, Cinta Hierro, Laura Layos, Cristina Bugés. HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies. International Journal of Molecular Sciences 2023; 24(14): 11403 doi: 10.3390/ijms241411403
|
| 10 |
Xiaoting Ma, Liyan Xue, Kai Ou, Xiu Liu, JunLin Chen, Lizhen Gao, Lin Yang. Significant effect of posterior line treatment of HER2 positive advanced gastric cancer: A case report. Heliyon 2024; 10(7): e28923 doi: 10.1016/j.heliyon.2024.e28923
|
| 11 |
Ahmed Abdel Hadi, Ali El Hindawi, Amal Hareedy, Heba Khalil, Ranya Al Ashiry, Shady Elia, Ahmed Sadek, Mona Magdy, Rafatt Atta, Amgad Anas, Hisham Bakr, Olfat Hammam. Her2/neu Protein Expression and Oncogene Amplification in Gastric Carcinoma with Clinico-Pathological Correlation in Egyptian Patients. Open Access Macedonian Journal of Medical Sciences 2016; 4(4): 535 doi: 10.3889/oamjms.2016.104
|
| 12 |
Chang Liu, Feng Li, Hong-Wei Zheng, Qiu-Xia Feng, Xi-Sheng Liu, Liang Qi, Yu-Dong Zhang. Relationship between CT characteristics and human epidermal growth factor receptor 2 expression in gastric cancers. Chinese Journal of Academic Radiology 2020; 3(3): 137 doi: 10.1007/s42058-020-00041-3
|
| 13 |
Chen Xu, Yalan Liu, Dongxian Jiang, Qian Li, Xiaowen Ge, Ying Zhang, Jie Huang, Jieakesu Su, Yuan Ji, Jun Hou, Shaohua Lu, Yingyong Hou, Tianshu Liu. Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type. Oncotarget 2017; 8(20): 33185 doi: 10.18632/oncotarget.16567
|
| 14 |
Miaozhen Qiu, Yixin Zhou, Xinke Zhang, Zixian Wang, Fang Wang, Jianyong Shao, Jiabin Lu, Ying Jin, Xiaoli Wei, Dongsheng Zhang, Fenghua Wang, Yuhong Li, Dajun Yang, Ruihua Xu. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-823
|
| 15 |
Hyeongbin Kim, SangHyuk Seo, KwangHee Kim, Yo-Han Park, MinSung An, HyungJoo Baik, ChangSoo Choi, SangHoon Oh. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1652-2
|
| 16 |
Mehmet Mihmanli, Enver Ilhan, Ufuk Oguz Idiz, Ali Alemdar, Uygar Demir. Recent developments and innovations in gastric cancer. World Journal of Gastroenterology 2016; 22(17): 4307-4320 doi: 10.3748/wjg.v22.i17.4307
|
| 17 |
Dang Anh Thu Phan, Vu Thien Nguyen, Thi Ngoc Ha Hua, Quoc Dat Ngo, Thi Phuong Thao Doan, Sao Trung Nguyen, Anh Tu Thai, Van Thanh Nguyen. HER2 Status and Its Heterogeneity in Gastric Carcinoma of Vietnamese Patient. Journal of Pathology and Translational Medicine 2017; 51(4): 396 doi: 10.4132/jptm.2017.04.24
|
| 18 |
Ling-Fang Zhang, Jun-Liang Li, Yan-Hong Wang, Xiao-Hui Tai, Le Liu, Xu-Xia Zhang, Yi-Wei An, Hong-Ling Li. The Correlation Between 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Semiquantitative Parameters and the Clinical Features and Pathological Biological Indexes of Gastric Cancer. Cancer Biotherapy and Radiopharmaceuticals 2023; 38(6): 364 doi: 10.1089/cbr.2020.4150
|
| 19 |
Reetu Mukherji, Chao Yin, Rumaisa Hameed, Ali Z. Alqahtani, Monika Kulasekaran, Aiwu R. He, Benjamin A. Weinberg, John L. Marshall, Marion L. Hartley, Marcus S. Noel. The current state of molecular profiling in gastrointestinal malignancies. Biology Direct 2022; 17(1) doi: 10.1186/s13062-022-00322-0
|
| 20 |
Xin-Zu Chen, Wei-Han Zhang, Hai-Ning Chen, Jian-Ping Liu, Du He, Yang Liu, Kai Liu, Xiao-Long Chen, Xian-Ming Mo, Zong-Guang Zhou, Jian-Kun Hu. Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study. Oncotarget 2016; 7(17): 23647 doi: 10.18632/oncotarget.8145
|
| 21 |
Na Wang, Xinxin Wang, Wenya Li, Huajun Ye, Hongzhao Bai, Jiansheng Wu, Mengjun Chen. <p>Contrast-Enhanced CT Parameters of Gastric Adenocarcinoma: Can Radiomic Features Be Surrogate Biomarkers for HER2 Over-Expression Status?</p>. Cancer Management and Research 2020; : 1211 doi: 10.2147/CMAR.S230138
|
| 22 |
Lucas Faria Abrahao-Machado, Cristovam Scapulatempo-Neto. HER2 testing in gastric cancer: An update. World Journal of Gastroenterology 2016; 22(19): 4619-4625 doi: 10.3748/wjg.v22.i19.4619
|
| 23 |
Ling Chen, Liyu Wang, Xin Li, Guangtao Zhang, Zhaoyan Li, Yanwen Wang. Clinic-Pathological Characteristics and Prognostic Value of PD-L1 and HER2 in Gastric Cancer. DNA and Cell Biology 2021; 40(2): 405 doi: 10.1089/dna.2020.6232
|
| 24 |
Ryo Wada, Kenichi Hirabayashi, Nobuyuki Ohike, Eiichi Morii. New guidelines for HER2 pathological diagnostics in gastric cancer. Pathology International 2016; 66(2): 57 doi: 10.1111/pin.12390
|
| 25 |
Abhilash V. B., Manas Kumar Behera, Shashikant C. U. Patne, Sunit Kumar Shukla, Vinod Kumar Dixit. Clinicopathological Significance and Prognostic Role of Her2neu Protein Expression in Patients with Carcinoma Stomach: A Prospective Study from Northern India. South Asian Journal of Cancer 2023; 12(02): 135 doi: 10.1055/s-0042-1759601
|
| 26 |
Melin GECER, Nur BÜYÜKPINARBAŞILI, Seval TURNA, Mehmet BEŞİROĞLU, Zuhal GUCIN. Comparison of human epidermal growth factor receptor 2 and cancer stem cell markers like CD44 and CD133 expressions with clinicopathological parameters in gastric cancer. The European Research Journal 2023; 9(5): 1015 doi: 10.18621/eurj.1296567
|
| 27 |
Zhen-Jun Tong, Ning-Yao Shi, Zhi-Ji Zhang, Xiao-Dong Yuan, Xiao-Ming Hong. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis. Bioscience Reports 2017; 37(4) doi: 10.1042/BSR20170121
|
| 28 |
Fatemeh Amirmoezi, Bita Geramizadeh. Molecular Classification of Gastric Cancer With Emphasis on PDL-1 Expression: The First Report From Iran. Clinical Pathology 2022; 15 doi: 10.1177/2632010X221096378
|
| 29 |
Gero Brockhoff. Complementary Tumor Diagnosis by Single Cell–Based Cytogenetics Using Multi‐marker Fluorescence In Situ Hybridization (mFISH). Current Protocols 2023; 3(11) doi: 10.1002/cpz1.942
|
| 30 |
Hideyuki Abe, Akihiko Kawahara, Koichi Azuma, Yuichi Murakami, Yorihiko Takase, Yoshiki Naito, Jun Akiba. Copy number gain in recurrent anaplastic lymphoma kinase (ALK) rearrangement‐lung adenocarcinoma in the pleural effusion. Diagnostic Cytopathology 2018; 46(9): 744 doi: 10.1002/dc.23936
|
| 31 |
Mickael Chevallay, Charles-Henri Wassmer, Pouya Iranmanesh, Minoa K Jung, Stefan P Mönig. Multimodal treatment in oligometastatic gastric cancer. World Journal of Gastrointestinal Oncology 2022; 14(2): 434-449 doi: 10.4251/wjgo.v14.i2.434
|
| 32 |
L Liang, J-Y Fang, J Xu. Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy. Oncogene 2016; 35(12): 1475 doi: 10.1038/onc.2015.209
|
| 33 |
Guo-Cai Li, Hong-Wei Zhang, Hong-Gang Tian, Yun Zhao, Qin-Xian Huang, Ze-Yu Xu, Xiao-Hui Xi, Kai Zhang. Clinicopathological difference between gastric cancer in the lesser curvature and gastric cancer in the greater curvature. Medicine 2022; 101(33): e29984 doi: 10.1097/MD.0000000000029984
|
| 34 |
Ravi M Swami, Binal N Patel, Rachana Lakhe, Ravindra Nimbargi. Study of prognostic indicators and Her2neu expression in gastric adenocarcinomas – A tertiary care centre study. Indian Journal of Pathology and Oncology 2021; 8(1): 104 doi: 10.18231/j.ijpo.2021.021
|
| 35 |
Meltem Baykara, Mustafa Benekli, Ozgur Ekinci, Sultan Cigdem Irkkan, Halit Karaca, Umut Demirci, Muhammed Bulent Akinci, Olcun Umit Unal, Faysal Dane, Fatma Paksoy Turkoz, Ozan Balakan, Eylem Pinar Eser, Selcuk Cemil Ozturk, Metin Ozkan, Berna Oksuzoglu, Alper Sevinc, Necla Demir, Hakan Harputluoglu, Bulent Yalcin, Ugur Coskun, Aytug Uner, Ahmet Ozet, Suleyman Buyukberber. Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers. Journal of Gastrointestinal Surgery 2015; 19(9): 1565 doi: 10.1007/s11605-015-2888-y
|
| 36 |
Jia-Bin Liao, Huai-Pao Lee, Hsiao-Ting Fu, Herng-Sheng Lee. Assessment of EGFR and ERBB2 (HER2) in Gastric and Gastroesophageal Carcinomas: EGFR Amplification is Associated With a Worse Prognosis in Early Stage and Well to Moderately Differentiated Carcinoma. Applied Immunohistochemistry & Molecular Morphology 2018; 26(6): 374 doi: 10.1097/PAI.0000000000000437
|
| 37 |
Matthew S. Strand, Albert Craig Lockhart, Ryan C. Fields. Genetics of Gastric Cancer. Surgical Clinics of North America 2017; 97(2): 345 doi: 10.1016/j.suc.2016.11.009
|
| 38 |
Haoyu Shi, Min Zhang, Youbo Zhang. Construction of a prognostic model for autophagy in Wilm's tumor. Pediatric Surgery International 2024; 40(1) doi: 10.1007/s00383-024-05712-1
|
| 39 |
Akiko Kawano Nagatsuma, Masaki Aizawa, Takeshi Kuwata, Toshihiko Doi, Atsushi Ohtsu, Hirofumi Fujii, Atsushi Ochiai. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma. Gastric Cancer 2015; 18(2): 227 doi: 10.1007/s10120-014-0360-4
|
| 40 |
Kentaro Fujiwara, Atsushi B. Tsuji, Hitomi Sudo, Aya Sugyo, Hiroki Akiba, Hiroko Iwanari, Osamu Kusano-Arai, Kouhei Tsumoto, Toshimitsu Momose, Takao Hamakubo, Tatsuya Higashi. 111In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis. Annals of Nuclear Medicine 2020; 34(1): 13 doi: 10.1007/s12149-019-01408-y
|
| 41 |
Toshihiko Doi, Kohei Shitara, Yoichi Naito, Akihiko Shimomura, Yasuhiro Fujiwara, Kan Yonemori, Chikako Shimizu, Tatsunori Shimoi, Yasutoshi Kuboki, Nobuaki Matsubara, Atsuko Kitano, Takahiro Jikoh, Caleb Lee, Yoshihiko Fujisaki, Yusuke Ogitani, Antoine Yver, Kenji Tamura. Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study. The Lancet Oncology 2017; 18(11): 1512 doi: 10.1016/S1470-2045(17)30604-6
|
| 42 |
Misaki Yokokawa, Kei‐ichi Morita, Yu Oikawa, Kou Kayamori, Kei Sakamoto, Tohru Ikeda, Hiroyuki Harada. Co‐expression of EGFR and MET has a synergistic effect on the prognosis of patients with oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 2020; 49(3): 235 doi: 10.1111/jop.12977
|
| 43 |
Vincent Drubay, Frederiek Nuytens, Florence Renaud, Antoine Adenis, Clarisse Eveno, Guillaume Piessen. Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: Updated review of definition, classification and therapeutic management. World Journal of Gastrointestinal Oncology 2022; 14(8): 1406-1428 doi: 10.4251/wjgo.v14.i8.1406
|
| 44 |
Zhihao Zhang, Mengmeng Dou, Xiaofang Yao, Hao Tang, Zhubo Li, Xiaoyan Zhao. Potential Biomarkers in Diagnosis of Human Gastric Cancer. Cancer Investigation 2016; 34(3): 115 doi: 10.3109/07357907.2015.1114122
|
| 45 |
Paul Chih-Hsueh Chen, Chueh-Chuan Yen, Giun-Yi Hung, Chin-Chen Pan, Wei-Ming Chen. Gene amplification and tumor grading in parosteal osteosarcoma. Journal of the Chinese Medical Association 2019; 82(12): 889 doi: 10.1097/JCMA.0000000000000211
|
| 46 |
Hong-Bo Wang, Xiao-Feng Liao, Jian Zhang. Clinicopathological factors associated with HER2-positive gastric cancer. Medicine 2017; 96(44): e8437 doi: 10.1097/MD.0000000000008437
|
| 47 |
Toshimitsu Yamaoka, Motoi Ohba, Tohru Ohmori. Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms. International Journal of Molecular Sciences 2017; 18(11): 2420 doi: 10.3390/ijms18112420
|
| 48 |
Ruohua Chen, Xiang Zhou, Jianjun Liu, Gang Huang. Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer. Journal of Nuclear Medicine 2016; 57(7): 1040 doi: 10.2967/jnumed.115.171165
|
| 49 |
Y. Wang, L. He, Y. Cheng. An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis. Clinical and Translational Oncology 2018; 20(2): 212 doi: 10.1007/s12094-017-1711-5
|
| 50 |
Yasuhiro Oono, Takeshi Kuwata, Kenji Takashima, Yusuke Yoda, Hiroaki Ikematsu, Kohei Shitara, Takahiro Kinoshita, Tomonori Yano. Clinicopathological features and endoscopic findings of HER2-positive gastric cancer. Surgical Endoscopy 2018; 32(9): 3964 doi: 10.1007/s00464-018-6138-8
|
| 51 |
Mengying Xu, Song Liu, Lin Li, Xiangmei Qiao, Changfeng Ji, Lingyu Tan, Zhengyang Zhou. Development and validation of multivariate models integrating preoperative clinicopathological and radiographic findings to predict HER2 status in gastric cancer. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-18433-z
|
| 52 |
Olcun Umit Unal, Seval Akay, Gurkan Gul, Murat Keser, Birsen Gizem Ozamrak, Dudu Solakoglu Kahraman, Mihriban Erdogan. Impact of HER2-Low Status in Metastatic Gastric Cancer: A Real-World Retrospective Cohort Study. Oncology 2024; 102(10): 889 doi: 10.1159/000537839
|
| 53 |
Jingyu Deng, Jiping Wang, Han Liang. Surgery for Gastric Cancer. 2019; : 45 doi: 10.1007/978-3-662-45583-8_2
|
| 54 |
Min Yan, Barbara A. Parker, Richard Schwab, Razelle Kurzrock. HER2 aberrations in cancer: Implications for therapy. Cancer Treatment Reviews 2014; 40(6): 770 doi: 10.1016/j.ctrv.2014.02.008
|
| 55 |
Marta Smolińska, Dariusz Grzanka, Paulina Antosik, Anna Kasperska, Izabela Neska-Długosz, Jakub Jóźwicki, Anna Klimaszewska-Wiśniewska. HER2, NF-κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological Parameters. Disease Markers 2019; 2019: 1 doi: 10.1155/2019/6315936
|
| 56 |
Yaohua Hu, Qinghua Xie, Jumei Zhao, Runze Yang, Jing Qin, Hui Li, Yong Zhao, Xiong Du, Changhong Shi. Interaction between the EPHB2 receptor and EFNB1 ligand drives gastric cancer invasion and metastasis via the Wnt/β-catenin/FAK pathway. International Journal of Biological Macromolecules 2024; 258: 128848 doi: 10.1016/j.ijbiomac.2023.128848
|
| 57 |
Yu Oikawa, Kei‐ichi Morita, Kou Kayamori, Kousuke Tanimoto, Kei Sakamoto, Hiroto Katoh, Shumpei Ishikawa, Johji Inazawa, Hiroyuki Harada. Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma. Cancer Science 2017; 108(2): 256 doi: 10.1111/cas.13126
|
| 58 |
Surinder Kumar Atri, Virender Mohan Rana, Vijant Singh Chandial. HER-2/NEU EXPRESSION IN STOMACH AND GASTRO-OESOPHAGEAL JUNCTION CARCINOMA IN ENDOSCOPIC BIOPSY SPECIMENS. Journal of Evolution of Medical and Dental Sciences 2017; 6(88): 6123 doi: 10.14260/jemds/2017/1330
|
| 59 |
Na Kong, Wendong Li, Jun Zhang, Xin Wang, Lin Hu, Qiqi Xu. TRPM8 as a Potential Biomarker and Therapeutic Target for Gastric
Cancer Identified by a Combination of Text Mining and RNA Sequencing. Current Gene Therapy 2023; 23(5): 391 doi: 10.2174/1566523223666230529142423
|
| 60 |
Shih-Min Pai, Kuo-Hung Huang, Ming-Huang Chen, Wen-Liang Fang, Yee Chao, Su-Shun Lo, Anna Fen-Yau Li, Chew-Wun Wu, Yi-Ming Shyr. Cardia Gastric Cancer Is Associated With Increased PIK3CA Amplifications and HER2 Expression Than Noncardia Gastric Cancer According to Lauren Classification. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.632609
|
| 61 |
Maria Bonomi, Daniele Spada, Gian Luca Baiocchi, Andrea Celotti, Matteo Brighenti, Giulia Grizzi. Targeting HER2 in Gastroesophageal Adenocarcinoma: Molecular Features and Updates in Clinical Practice. International Journal of Molecular Sciences 2024; 25(7): 3876 doi: 10.3390/ijms25073876
|
| 62 |
Benjamin L Solomon, Ignacio Garrido-Laguna. Upper Gastrointestinal Malignancies in 2017: Current Perspectives and Future Approaches. Future Oncology 2018; 14(10): 947 doi: 10.2217/fon-2017-0597
|
| 63 |
Xiaoyan Liu, Xiaoling Wang, Bo Wang, Guoping Ren, Wei Ding. HER2 Gene Amplification by Fluorescence In Situ Hybridization (FISH) Compared With Immunohistochemistry (IHC) in 122 Equivocal Gastric Cancer Cases. Applied Immunohistochemistry & Molecular Morphology 2016; 24(7): 459 doi: 10.1097/PAI.0000000000000219
|
| 64 |
Jian He, Hua Shi, Zhuping Zhou, Jun Chen, Wenxian Guan, Hao Wang, Haiping Yu, Song Liu, Zhengyang Zhou, Xiaofeng Yang, Tian Liu. Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1726-7
|
| 65 |
Lorenzo Fornaro, Andrea Spallanzani, Ferdinando de Vita, Domenico D’Ugo, Alfredo Falcone, Laura Lorenzon, Giuseppe Tirino, Stefano Cascinu. Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN). Cancers 2021; 13(6): 1304 doi: 10.3390/cancers13061304
|
| 66 |
Huifang Lv, Junling Zhang, Keran Sun, Caiyun Nie, Beibei Chen, Jianzheng Wang, Weifeng Xu, Saiqi Wang, Yingjun Liu, Xiaobing Chen. Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.580045
|
| 67 |
Gen Tsujio, Koji Maruo, Yurie Yamamoto, Tomohiro Sera, Atsushi Sugimoto, Hiroaki Kasashima, Yuichiro Miki, Mami Yoshii, Tatsuro Tamura, Takahiro Toyokawa, Hiroaki Tanaka, Kazuya Muguruma, Masaichi Ohira, Masakazu Yashiro. Significance of tumor heterogeneity of p-Smad2 and c-Met in HER2-positive gastric carcinoma with lymph node metastasis. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09681-3
|
| 68 |
Zhen Xiang, Xia Huang, Jiexuan Wang, Jun Zhang, Jun Ji, Ranlin Yan, Zhenggang Zhu, Wei Cai, Yingyan Yu. Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00861
|